Cargando…
Assessment of HIV molecular surveillance capacity in the European Union, 2016
Expanding access to HIV antiretroviral treatment is expected to decrease HIV incidence and acquired immunodeficiency syndrome (AIDS) mortality. However, this may also result in increased HIV drug resistance (DR). Better monitoring and surveillance of HIV DR is required to inform treatment regimens a...
Autores principales: | Keating, Patrick, Pharris, Anastasia, Leitmeyer, Katrin, De Angelis, Stefania, Wensing, Annemarie, Amato-Gauci, Andrew J, Broberg, Eeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727594/ https://www.ncbi.nlm.nih.gov/pubmed/29233253 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.49.17-00269 |
Ejemplares similares
-
Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016
por: van Sighem, Ard, et al.
Publicado: (2017) -
Potential adjustment methodology for missing data and reporting delay in the HIV Surveillance System, European Union/European Economic Area, 2015
por: Rosinska, Magdalena, et al.
Publicado: (2018) -
Piloting a surveillance system for HIV drug resistance in the European Union
por: van de Laar, Marita JW, et al.
Publicado: (2019) -
Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016) -
Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016
por: Harvala, Heli, et al.
Publicado: (2017)